InMed Pharmaceuticals Inc.

The momentum for this stock is not very good. InMed Pharmaceuticals Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in InMed Pharmaceuticals Inc..
Log in to see more information.
INM Fundamental Data by TradingView

News

Micro-cap InMed Pharmaceuticals mentioned positively in Gene Online report
Micro-cap InMed Pharmaceuticals mentioned positively in Gene Online report

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

InMed Pharmaceuticals Strengthens Patent Portfolio with Issuance of Three U.S. Patents
InMed Pharmaceuticals Strengthens Patent Portfolio with Issuance of Three U.S. Patents

Newsfile Corp. - News Releases InMed's intellectual property portfolio totals 13 patent families covering new chemical entities, formulations, manufacturing methods and methods of useVancouver, British Columbia--(Newsfile Corp...\n more…

InMed Pharmaceuticals Demonstrates INM-901 as an Oral Formulation Targeting Alzheimer's Disease
InMed Pharmaceuticals Demonstrates INM-901 as an Oral Formulation Targeting Alzheimer's Disease

Newsfile Corp. - News Releases High bioavailability of INM-901 oral formulation provides similar drug concentration levels in the brain as intraperitoneal (IP) injectionVancouver, British Columbia--(Newsfile Corp. - August 20...\n more…

InMed Pharmaceuticals Inc. (NASDAQ:INM) Short Interest Update
InMed Pharmaceuticals Inc. (NASDAQ:INM) Short Interest Update

Ticker Report InMed Pharmaceuticals Inc. (NASDAQ:INM - Get Free Report) was the target of a significant increase in short interest in the month of July. As of July 31st, there was short interest totalling 253,200...\n more…

InMed Pharmaceuticals Announces Favorable Behavioral Outcomes with INM-901 in Long-Term Preclinical Alzheimer's Disease Study, Confirming Previous Short-Term Pilot Study Data
InMed Pharmaceuticals Announces Favorable Behavioral Outcomes with INM-901 in Long-Term Preclinical Alzheimer's Disease Study, Confirming Previous Short-Term Pilot Study Data

Newsfile Corp. - News Releases Results confirm improvements in cognitive function, memory and locomotor activity Achieved statistical significance in certain behavioral assessments Additional molecular analyses ongoing to...\n more…

InMed Pharmaceuticals (NASDAQ:INM) & CannTrust (OTCMKTS:CNTTF) Head-To-Head Analysis
InMed Pharmaceuticals (NASDAQ:INM) & CannTrust (OTCMKTS:CNTTF) Head-To-Head Analysis

Zolmax InMed Pharmaceuticals (NASDAQ:INM - Get Free Report) and CannTrust (OTCMKTS:CNTTF - Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two...\n more…